Suchergebnisse - "Rochais, Christophe"

PubPharm (134)

61

A chemical screen identifies two novel small compounds that alter Arabidopsis thaliana pollen tube growth

enthalten in: BMC plant biology | 2019

von Laggoun, F. | Dardelle, F. | Dehors, J. | +6

62

Novel multitarget-directed ligands targeting acetylcholinesterase and σ1 receptors as lead compounds for treatment of Alzheimer's disease : Synthesis, evaluation, and structural characterization of their complexes with acetylcholinesterase

enthalten in: European journal of medicinal chemistry | 2019

von Lalut, J. | Santoni, G. | Karila, D. | +9

63

A Novel in vivo Anti-amnesic Agent, Specially Designed to Express Both Acetylcholinesterase (AChE) Inhibitory, Serotonergic Subtype 4 Receptor (5-HT4R) Agonist and Serotonergic Subtype 6 Receptor (5-HT6R) Inverse Agonist Activities, With a Potential Interest Against Alzheimer's Disease

enthalten in: Frontiers in aging neuroscience | 2019

von Hatat, B. | Yahiaoui, S. | Lecoutey, C. | +6

64

Facing the complexity of Alzheimer's disease

enthalten in: Future medicinal chemistry | 2019

von Dallemagne, P. | Rochais, C.

65

Benzylphenylpyrrolizinones with Anti-amyloid and Radical Scavenging Effects, Potentially Useful in Alzheimer's Disease Treatment

enthalten in: ChemMedChem | 2017

von Jourdan, J. | Since, M. | El Kihel, L. | +8

66

Modulating 5-HT4 and 5-HT6 receptors in Alzheimer's disease treatment

enthalten in: Future medicinal chemistry | 2017

von Lalut, J. | Karila, D. | Dallemagne, P. | +1

67

Benzylphenylpyrrolizinones with Anti‐amyloid and Radical Scavenging Effects, Potentially Useful in Alzheimer's Disease Treatment

enthalten in: ChemMedChem | 2017

von Jourdan, J. | Since, M. | El Kihel, L. | +8

68

Back Cover: Benzylphenylpyrrolizinones with Anti‐amyloid and Radical Scavenging Effects, Potentially Useful in Alzheimer's Disease Treatment (ChemMedChem 12/2017)

enthalten in: ChemMedChem | 2017

von Jourdan, J. | Since, M. | El Kihel, L. | +8

69

Design, synthesis, and pharmacological evaluation of multitarget-directed ligands with both serotonergic subtype 4 receptor (5-HT4R) partial agonist and 5-HT6R antagonist activities, as potential treatment of Alzheimer's disease

enthalten in: European journal of medicinal chemistry | 2016

von Yahiaoui, S. | Hamidouche, K. | Ballandonne, C. | +6

70

Synthesis and evaluation of novel serotonin 4 receptor radiotracers for single photon emission computed tomography

enthalten in: European journal of medicinal chemistry | 2016

von Lalut, J. | Tournier, B. | Cailly, T. | +9